Search

everythinglearnresearchcommunity

for

Search:↓

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

Early treatment helps stop hair loss in women of color.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

New effective scar treatments are urgently needed due to the current options' limited success.

More research is needed to find the best long-term treatments for Alopecia Areata.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

Beard hair loss can signal early diabetes and thyroid issues, treatable with specific cream.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

The document concludes that improving the appearance of posttraumatic facial scars is possible with careful treatment and realistic expectations.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Triamcinolone acetonide mesotherapy may be effective for treating patchy hair loss in alopecia areata.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

The document explains various skin conditions and their treatments.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Laser hair removal can help treat acne keloidalis nuchae, but results vary and a standard scoring system is needed.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Lipedematous scalp is mainly caused by an increase in fat tissue under the skin and is different from lipedematous alopecia.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.